E.I. Dupont De Nemours & Co. v. Synvina C.V.
Court of Appeals for the Federal Circuit
1Opinion of the Court
Lourie, Circuit Judge.
E. I. du Pont de Nemours and Company and Archer-Daniels-Midland Company (collectively, "DuPont") appeal from an inter partes review ("IPR") decision of the United States Patent and Trademark Office Patent Trial and Appeal Board (the "Board"). See DuPont v. Furanix Techs. B.V. , No. IPR2015-01838, Paper No. 43, slip op. (P.T.A.B. Mar. 3, 2017) (" Decision "). The Board held that DuPont failed *999 to prove by preponderant evidence that claims 1-5 and 7-9 of U.S. Patent 8,865,921 ("'921 patent") would have been obvious at the time of the claimed invention. We conclude that the…
2Cases cited30 opinions
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Consolidated Edison Co. v. National Labor Relations BoardSupreme Court of the United States · 1938
- Spokeo, Inc. v. RobinsSupreme Court of the United States · 2016
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
25 more not listed; retrieve them via the Exa API.
3Cited by37 opinions
- Avx Corporation v. Presidio Components, Inc.Court of Appeals for the Federal Circuit · 2019
- Amerigen Pharmaceuticals v. Ucb Pharma GmbhCourt of Appeals for the Federal Circuit · 2019
- Adapt Pharma Operations v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2022
- Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb CompanyCourt of Appeals for the Federal Circuit · 2019
- Grit Energy Solutions, LLC v. Oren Technologies, LLCCourt of Appeals for the Federal Circuit · 2020
32 more not listed; retrieve them via the Exa API.